Clinical Trial Update: Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study sponsored by the University of Chicago evaluating chemotherapy in Nigerian women with triple-negative breas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: University of Chicago | Conditions: Triple Negative Breast Cancer | Phase 2 | Status: RECRUITING